Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/03/141
Active ingredient: 2-chloro-9-[2-deoxy-2-fluoro-ß-D-arabinofuranosyl]adenine.
Indication: Treatment of acute myeloid leukaemia
Sponsor: Genzyme Europe B.V.
Gooimeer 10, NL-1411 DD Naarden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/05/2003 Orphan designation EMEA/OD/065/02 (2003)1577 of 08/05/2003
05/02/2007 Change of address of sponsor
27/05/2008 Transfer of orphan designation EMEA/OD/065/02/T/01 (2008)2288 of 23/05/2008
08/07/2014 Removal of orphan designation from Community Register